Microbiological Profile and Antimicrobial Susceptibility in Surgical Site Infections Following Hollow Viscus Injury

[1]  D. Nicolau,et al.  Surgical site infections: does inadequate antibiotic therapy affect patient outcomes? , 2009, Surgical infections.

[2]  W. Ko,et al.  Increasing extended-spectrum beta-lactamase production and quinolone resistance among Gram-negative bacilli causing intra-abdominal infections in the Asia/Pacific region: data from the Smart Study 2002-2006. , 2009, The Journal of infection.

[3]  H. Dupont,et al.  Clinical and microbiological profiles of community-acquired and nosocomial intra-abdominal infections: results of the French prospective, observational EBIIA study. , 2009, The Journal of antimicrobial chemotherapy.

[4]  E. Bouza,et al.  Evolution of antimicrobial susceptibility patterns of aerobic and facultative gram-negative bacilli causing intra-abdominal infections: results from the SMART studies 2003-2007. , 2008, Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia.

[5]  E. Klein,et al.  The burden of vancomycin-resistant enterococcal infections in US hospitals, 2003 to 2004. , 2008, Diagnostic microbiology and infectious disease.

[6]  K. Inaba,et al.  Analysis of 178 Penetrating Stomach and Small Bowel Injuries , 2008, World Journal of Surgery.

[7]  David L. Smith,et al.  Hospitalizations and Deaths Caused by Methicillin-Resistant Staphylococcus aureus, United States, 1999–2005 , 2007, Emerging infectious diseases.

[8]  F. Baquero,et al.  In vitro susceptibilities of Escherichia coli isolated from patients with intra-abdominal infections worldwide in 2002-2004: results from SMART (Study for Monitoring Antimicrobial Resistance Trends). , 2006, Surgical infections.

[9]  B. Laviolle,et al.  Factors associated with multidrug-resistant bacteria in secondary peritonitis: impact on antibiotic therapy. , 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[10]  F. Baquero,et al.  In vitro susceptibilities of aerobic and facultatively anaerobic Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2004 results from SMART (Study for Monitoring Antimicrobial Resistance Trends). , 2006, The Journal of antimicrobial chemotherapy.

[11]  F. Baquero,et al.  [Patterns of susceptibility to antibiotics of Enterobacteriaceae causing intra-abdominal infection in Spain: SMART 2003 study outcomes]. , 2006, Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia.

[12]  R. Gaynes,et al.  Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992-2003. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  R. Herings,et al.  Inappropriate initial treatment of secondary intra-abdominal infections leads to increased risk of clinical failure and costs. , 2005, British journal of clinical pharmacology.

[14]  F. Baquero,et al.  In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: the 2003 Study for Monitoring Antimicrobial Resistance Trends (SMART). , 2005, The Journal of antimicrobial chemotherapy.

[15]  M. Bonten,et al.  Beta-lactam susceptibilities and prevalence of ESBL-producing isolates among more than 5000 European Enterobacteriaceae isolates. , 2004, International journal of antimicrobial agents.

[16]  A. M. Peña,et al.  Intra-abdominal infection in patients with abdominal trauma. , 2004, Archives of surgery.

[17]  S. Sen,et al.  Effect of inappropriate initial empiric antibiotic therapy on outcome of patients with community-acquired intra-abdominal infections requiring surgery , 2004, European Journal of Clinical Microbiology and Infectious Diseases.

[18]  O. Kirton,et al.  Analysis of 162 colon injuries in patients with penetrating abdominal trauma: concomitant stomach injury results in a higher rate of infection. , 2004, The Journal of trauma.

[19]  E. P. Dellinger,et al.  Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  S. Cosgrove,et al.  The impact of antimicrobial resistance on health and economic outcomes. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  G. Eliopoulos.  Quinupristin-dalfopristin and linezolid: evidence and opinion. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  J. Devlin,et al.  Characteristics of prophylactic antibiotic strategies after penetrating abdominal trauma at a level I urban trauma center: a comparison with the East guidelines. , 2002, The Journal of trauma.

[23]  J. Lefrant,et al.  Evaluation of antimicrobial therapy management of 120 consecutive patients with secondary peritonitis. , 2002, The Journal of antimicrobial chemotherapy.

[24]  G. Velmahos,et al.  Wound Management after Colon Injury: Open or Closed? A Prospective Randomized Trial , 2002, The American surgeon.

[25]  M. Girvent,et al.  Postoperative enterococcal infection after treatment of complicated intra‐abdominal sepsis , 2002, The British journal of surgery.

[26]  O. Kirton,et al.  Perioperative antibiotic use in high-risk penetrating hollow viscus injury: a prospective randomized, double-blind, placebo-control trial of 24 hours versus 5 days. , 2000, The Journal of trauma.

[27]  C. Ebener,et al.  Microbiology of postoperative peritonitis , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  B. Murray,et al.  Vancomycin-resistant enterococcal infections. , 2000, The New England journal of medicine.

[29]  A. Encke,et al.  A Prospective, Randomised Comparison of Single- vs. Multiple-Dose Antibiotic Prophylaxis in Penetrating Trauma , 1999, Chemotherapy.

[30]  Karyn M. Warsow,et al.  A trial of ciprofloxacin and metronidazole vs gentamicin and metronidazole for penetrating abdominal trauma. , 1998, Archives of surgery.

[31]  T. Fabian,et al.  Impact of stomach and colon injuries on intra-abdominal abscess and the synergistic effect of hemorrhage and associated injury. , 1998, The Journal of trauma.

[32]  K. Ganesan,et al.  How many antibiotics are necessary to treat abdominal trauma victims? , 1997, The American surgeon.

[33]  J. Bohnen,et al.  Management of Intra-abdominal Infections: The Case for Intraoperative Cultures and Comprehensive Broad-spectrum Antibiotic Coverage , 1996 .

[34]  P. Montravers,et al.  Emergence of antibiotic-resistant bacteria in cases of peritonitis after intraabdominal surgery affects the efficacy of empirical antimicrobial therapy. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[35]  J. Bohnen,et al.  Definition of the role of enterococcus in intraabdominal infection: analysis of a prospective randomized trial. , 1995, Surgery.

[36]  J. Weigelt,et al.  Abdominal surgical wound infection is lowered with improved perioperative enterococcus and bacteroides therapy. , 1993, The Journal of trauma.

[37]  T. Fabian,et al.  Correlation of abdominal trauma index and injury severity score with abdominal septic complications in penetrating and blunt trauma. , 1992, The Journal of trauma.

[38]  R. Milne,et al.  Antibiotic treatment for surgical peritonitis. , 1991, Annals of surgery.

[39]  Durham Rm,et al.  Penetrating injuries to the stomach. , 1991, Surgery, gynecology & obstetrics.

[40]  D. Demetriades.  Antibiotic prophylaxis in penetrating abdominal injuries. , 1989, South African journal of surgery. Suid-Afrikaanse tydskrif vir chirurgie.

[41]  G. Coppa,et al.  A prospective comparison of two regimens of prophylactic antibiotics in abdominal trauma: cefoxitin versus triple drug. , 1984, The Journal of trauma.

[42]  H. Thadepalli,et al.  Microflora of the human small intestine. , 1979, American journal of surgery.

[43]  H. Thadepalli.  Principles and practice of antibiotic therapy for post-traumatic abdominal injuries. , 1979, Surgery, gynecology & obstetrics.

[44]  S. Broitman,et al.  Gastric acid barrier to ingested microorganisms in man: studies in vivo and in vitro , 1972, Gut.

[45]  J. Pérez,et al.  Patrones de sensibilidad a antimicrobianos de Enterobacteriaceae causantes de infecciones intraabdominales en España: resultados del estudio SMART 2003 , 2006 .

[46]  S. Cosgrove,et al.  Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[47]  D. Demetriades,et al.  Short-course antibiotic prophylaxis in penetrating abdominal injuries: ceftriaxone versus cefoxitin. , 1991, Injury.

[48]  D. Frommer.  Risk of infection after penetrating abdominal trauma , 1985 .

[49]  T. Fabian,et al.  Use of antibiotic prophylaxis in penetrating abdominal trauma. , 1982, Clinical therapeutics.